
Elisa M. Rice
Examiner (ID: 18639, Phone: (571)270-1582 , Office: P/2669 )
| Most Active Art Unit | 2669 |
| Art Unit(s) | 2669, 2624 |
| Total Applications | 370 |
| Issued Applications | 269 |
| Pending Applications | 9 |
| Abandoned Applications | 94 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16351813
[patent_doc_number] => 10792305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Therapeutic immune modulation using noble gas compositions
[patent_app_type] => utility
[patent_app_number] => 15/738025
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11809
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738025
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738025 | Therapeutic immune modulation using noble gas compositions | Jun 22, 2016 | Issued |
Array
(
[id] => 14326667
[patent_doc_number] => 10294337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Process for preparing poly(glycolide-co-lactide) copolymer microparticles
[patent_app_type] => utility
[patent_app_number] => 15/741995
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7828
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741995 | Process for preparing poly(glycolide-co-lactide) copolymer microparticles | Jun 20, 2016 | Issued |
Array
(
[id] => 13311087
[patent_doc_number] => 20180207080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS
[patent_app_type] => utility
[patent_app_number] => 15/744595
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744595 | COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS | Jun 15, 2016 | Abandoned |
Array
(
[id] => 12830917
[patent_doc_number] => 20180168811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => NOVEL BIODEGRADABLE AND NON-BIODEGRADABLE 3D PRINTED IMPLANTS AS A DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/736885
[patent_app_country] => US
[patent_app_date] => 2016-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736885 | NOVEL BIODEGRADABLE AND NON-BIODEGRADABLE 3D PRINTED IMPLANTS AS A DRUG DELIVERY SYSTEM | Jun 14, 2016 | Abandoned |
Array
(
[id] => 11120486
[patent_doc_number] => 20160317460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'NANO DELIVERY SYSTEMS FOR SIRNA'
[patent_app_type] => utility
[patent_app_number] => 15/181944
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 20447
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181944
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/181944 | NANO DELIVERY SYSTEMS FOR SIRNA | Jun 13, 2016 | Abandoned |
Array
(
[id] => 11928655
[patent_doc_number] => 09795633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne'
[patent_app_type] => utility
[patent_app_number] => 15/179815
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14090
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15179815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/179815 | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne | Jun 9, 2016 | Issued |
Array
(
[id] => 12831394
[patent_doc_number] => 20180168970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/735755
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735755 | Solubilizing agents for active or functional organic compounds | Jun 9, 2016 | Issued |
Array
(
[id] => 11735941
[patent_doc_number] => 09700510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Stabilized, sprayable emulsion containing active agent particles'
[patent_app_type] => utility
[patent_app_number] => 15/173849
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10958
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15173849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/173849 | Stabilized, sprayable emulsion containing active agent particles | Jun 5, 2016 | Issued |
Array
(
[id] => 11323726
[patent_doc_number] => 20160354336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Taxane Particles and Their Use'
[patent_app_type] => utility
[patent_app_number] => 15/174505
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14258
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174505
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174505 | Taxane particles and their use | Jun 5, 2016 | Issued |
Array
(
[id] => 11310100
[patent_doc_number] => 20160346210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'MEDICAL MAGNETIC PELLETS'
[patent_app_type] => utility
[patent_app_number] => 15/166285
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5020
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/166285 | MEDICAL MAGNETIC PELLETS | May 26, 2016 | Abandoned |
Array
(
[id] => 11713462
[patent_doc_number] => 20170181961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'NAIL COATING REMOVAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/164475
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8468
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15164475
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/164475 | NAIL COATING REMOVAL COMPOSITIONS | May 24, 2016 | Abandoned |
Array
(
[id] => 11066080
[patent_doc_number] => 20160263044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 15/163491
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7376
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163491 | METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM | May 23, 2016 | Abandoned |
Array
(
[id] => 14548677
[patent_doc_number] => 10342775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Vitamin A for parenteral administration
[patent_app_type] => utility
[patent_app_number] => 15/575984
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575984 | Vitamin A for parenteral administration | May 19, 2016 | Issued |
Array
(
[id] => 12765940
[patent_doc_number] => 20180147148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE
[patent_app_type] => utility
[patent_app_number] => 15/575350
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575350 | PHARMACEUTICAL COMPOSITION OF TERIFLUNOMIDE | May 10, 2016 | Abandoned |
Array
(
[id] => 12165272
[patent_doc_number] => 09884029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Morphine controlled release system'
[patent_app_type] => utility
[patent_app_number] => 15/149578
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 21370
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/149578 | Morphine controlled release system | May 8, 2016 | Issued |
Array
(
[id] => 11045937
[patent_doc_number] => 20160242895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Tissue Prostheses for Repairing, Reconstructing and Replacing Damaged or Diseased Biological Structures and Associated Tissue'
[patent_app_type] => utility
[patent_app_number] => 15/144902
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8147
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144902 | Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue | May 2, 2016 | Issued |
Array
(
[id] => 12302331
[patent_doc_number] => 09937130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Sustained delivery of therapeutic agents to an eye compartment
[patent_app_type] => utility
[patent_app_number] => 15/138132
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15859
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15138132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/138132 | Sustained delivery of therapeutic agents to an eye compartment | Apr 24, 2016 | Issued |
Array
(
[id] => 14291935
[patent_doc_number] => 10286075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Embolization particle
[patent_app_type] => utility
[patent_app_number] => 15/566254
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 15250
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566254 | Embolization particle | Apr 14, 2016 | Issued |
Array
(
[id] => 11016682
[patent_doc_number] => 20160213636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/092391
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16229
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092391 | Stable pharmaceutical composition and methods of using same | Apr 5, 2016 | Issued |
Array
(
[id] => 11016710
[patent_doc_number] => 20160213662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS'
[patent_app_type] => utility
[patent_app_number] => 15/086485
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 46532
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15086485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/086485 | Methods and devices for the treatment of ocular diseases in human subjects | Mar 30, 2016 | Issued |